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Abstract
            The clinical efficacy of ICD-CRT therapy depends on accurate sensing of intracardiac 
signals and sensing algorithms. We report the occurrence of sensing abnormality in a patient 
with ICD-CRT. In this patient, oversensing of myopotentials during strenuous muscular activity 
resulted in an inappropriate ICD-CRT discharge. Although modern ICDs are highly effective in 
detecting and terminating malignant tachyarrhythmias, their detection specificity must be 
improved. It is possible to find the mechanism of arrhythmia by EGM. Simple device 
reprogramming make it possible to avoid the oversensing of myopotentials.
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Introduction
               Inappropriate therapy (IT) for rhythm other than ventricular fibrillation (VF) and 
sustained ventricular tachycardia (VT) is the most common adverse event associated with 
implantable cardioverter defibrillators (ICDs). It occurs in 14-29% of patients, accounting for up 
to 50% of the total complications1,2. Most of the ITs are due to supraventricular tachycardia 
(SVT), such as paroxysmal supraventricular tachycardia (PSVT), atrial fibrillation (AF), and 
sinus tachycardia3. Other mechanisms are reconfirmation error due to a premature ventricular 
complex following a non-sustained ventricular tachycardia (NSVT), myopotential oversensing, 
T wave oversensing, lead fracture, device malfunction, electromagnetic interference, and far-
field R wave oversensing4,5.                                                                                                 
               This is the report of a rare case that myopotential oversensing was the cause of 
inappropriate therapy by an intact lead system of ICD-CRT.                                                         
Case   Presentation                                                                    
            The patient was a 50 - year-old male with a history of  coronary artery disease and 
previous myocardial infarction, with severe depression of  left  ventricular  function  and  NYHA 
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functional class III, who suffered from recurrent symptomatic ventricular tachycardia (VT). He 
had an ICD-CRT (Medtronic, InSync Marquis, model# 7277) implanted 3 years ago. A 
Medtronic lead (model # 6944) was placed in the right ventricular apex, another one (model # 
5076) in the right atrium and the third one (model #4193) in the lateral branch of the coronary 
sinus. ICD detection and treatment were programmed for three zones, ventricular fibrillation 
(VF) zone [320 ms, number of intervals detected (NID 9/12)], fast VT zone (via VF, 290 ms), 
VT zone (400 ms, NID 12/24). Antitachycardia pacing was programmed on. The sensed R wave 
amplitude was measured at 14 mV and the pacing threshold was 0.3 V and 0.9 V at 0.5 ms in the 
RV and the LV channels, respectively. During 3 years follow up after ICD implantation, the 
patient was followed regularly and had no episode of ventricular tachyarrhythmias or any 
discharge. No change in leads impedance was measured at different positions and no fracture or 
dislodgement was observed on chest radiographs.                                                         
            The patient presented to the pacemaker clinic, complaining of a single shock without any 
warning symptom. The patient received the shock while throwing a metallic object forcefully 
with   strong   muscular   contraction.   No   further   shock   was   felt   subsequently.   
            Twenty days later, the patient presented for regular follow up at the ICD clinic. Upon 
interrogation of the device, the counters revealed one episode of VF, for which a 29.7 J shock 
was delivered at the time of mentioned event (Figure 1). EGM revealed regular appearance of 
R-waves at an interval of about 610 ms; however there was undulating high frequency noise 
distorting the baseline corresponding to the time of forceful muscular contractions (Figure 2). 
This noise disappeared after delivery of the shock. The device interpreted (detect) this episode as 
VF, resulting in capacitor charging for VF therapy (charge). To determine the mechanism of 
electrical signal oversensing, we replicated brief noise by asking the patient to make a sudden 
strong forward movement against resistance. Impedance of the high voltage lead was within the 
normal range (50 Ohm) and the episode lasted for 9 seconds. Further interrogation of the 
defibrillator did not reveal any detrimental alteration in the pacing/ICD leads or the ICD circuit. 
To avoid inappropriate shock, we programmed longer duration of detection in the VF zone. No 
recurrence was observed during follow-up with the newly programmed parameters.
Discussion    
            This is a typical example of myopotential oversensing. Inappropriate therapy for rhythm 
other than ventricular fibrillation (VF) and sustained ventricular tachycardia (VT) is the most 
common adverse event associated with ICD implantation6,7. In the absence of damage to leads, 
electrical interference with ICD devices has rarely been identified as a cause of inappropriate 
therapy8. There are some reports about myopotential and / or diaphragmatic oversensing in 
pacemaker9-13. This is the report of a rare case with ICD-CRT  and intact lead system. Babuty et 
al reported inappropriate ICD discharge secondary to sensed myopotentials  during deep 
breathing or the Valsalva maneuver and other situations without lead failure12. Oversensing of 
diaphragmatic myopotentials was primarily observed in patients implanted with defibrillator 
leads providing "integrated bipolar" sensing14,15 In experience of Schulte et al  in 90% of cases 
the   reduction   of   maximum   sensitivity   was   effective   in   preventing   further   episodes   of 
nonadequate arrhythmia detection14. Therefore by recording intracardiac electrogram it was 
possible to demonstrate that the mechanism was an oversensing of the activity of the pectoralis 
muscles, because the small amplitude of the muscular potentials was detected by the ICD device 
as VF. The problem can be solved by changing the sensitivity of the device or prolonging the 
time of detection of ventricular fibrillation to avoid inappropriate shock.
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Figure 1
Figure 2
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